Covered recipient · General Payments record
TRENT LEAVITT
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$703.11
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $254.01 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $77.95 | 4 |
| PFIZER INC. | $72.44 | 3 |
| Amgen Inc. | $39.89 | 2 |
| GlaxoSmithKline, LLC. | $33.63 | 2 |
| Acerta Pharma LLC | $15.81 | 1 |
| Lilly USA, LLC | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.94 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117608118 | CMS |
| Amgen Inc. | $18.95 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117608120 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.81 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105399815 | CMS |
| GlaxoSmithKline, LLC. | $17.61 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116369911 | CMS |
| GlaxoSmithKline, LLC. | $16.02 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116663583 | CMS |
| Lilly USA, LLC | $14.29 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135468249 | CMS |
| Novo Nordisk Inc | $17.31 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097758277 | CMS |
| Novo Nordisk Inc | $20.59 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097246425 | CMS |
| Novo Nordisk Inc | $19.22 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096852852 | CMS |
| Novo Nordisk Inc | $20.83 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096909509 | CMS |
| PFIZER INC. | $23.26 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131024447 | CMS |
| PFIZER INC. | $23.07 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131518741 | CMS |
| PFIZER INC. | $26.11 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131696869 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.